Here there is a recent review about the status of MS treatments.
https://link.springer.com/article/10.10 ... 22-00939-9
It deals with:
- Diroximel fumarate
- Siponimod
- Ozanimod
- Ponesimod
- Ocrelizumab
- Ofatumumab
And some information about some others close to approval:
- Ublituximab
- Evobrutinib
- Tolebrutinib
- Remibrutinib
- Fenebrutinib
Review: Approved treatments since 2018
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1874 Views
-
Last post by frodo
-
- 0 Replies
- 1220 Views
-
Last post by NHE
-
- 0 Replies
- 1678 Views
-
Last post by frodo
-
- 1 Replies
- 1715 Views
-
Last post by frodo
-
- 0 Replies
- 1225 Views
-
Last post by frodo
-
- 0 Replies
- 2004 Views
-
Last post by NHE
-
- 1 Replies
- 1423 Views
-
Last post by NHE
-
- 0 Replies
- 1065 Views
-
Last post by frodo
-
- 0 Replies
- 1778 Views
-
Last post by frodo